Xylyx Bio announces development of disease-specific cell culture products to accelerate anti-fibrotic drug discovery and screening
Xylyx Bio, a pioneer in tissue-specific extracellular matrix biomaterials, today announced the development of substrates for anti-fibrotic drug discovery as the next stage of its pipeline of pre-clinical cell culture products. Read more >>